Med. praxi. 2013;10(3):104-106

Pneumococcal diseases and prevention among adult

MUDr.Lenka Petroušová, doc.MUDr.Luděk Rožnovský, CSc.
Klinika infekčního lékařství, Fakultní nemocnice Ostrava

Despite progress in treatment and prevention, Streptococcus pneumoniae remains a major cause of morbidity and mortality in the adult

population, especially in individuals aged 65 years or more and for risk groups. It causes mucosal infections of respiratory tract or invasive

pneumococcal infections including also meningitis. In the Czech Republic, the number of invasive pneumococcal diseases in children

decreased due to vaccination, in adults this trend has not yet been observed. For adults there are 2 vaccines registered including 23valent

polysaccharide vaccine and 13valent conjugate vaccine. An extension of adult vaccination is desirable due to the severity of the disease

and increasing resistance to antibiotics.

Obrázek 1. Pneumokoková pneumonie

Keywords: pneumococcus, adults, vaccination

Published: March 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petroušová L, Rožnovský L. Pneumococcal diseases and prevention among adult. Med. praxi. 2013;10(3):104-106.
Download citation

References

  1. Galský J. Pneumokokové infekce. In: Beneš J. Infekční lékařství. 1. vyd. Praha: Galén; 2009: 201-203.
  2. Swartz MN. Bacterial meningitis a view of the past 90 years. N Engl J Med. 2004; 351(18): 1826-1828. Go to original source... Go to PubMed...
  3. Chlíbek R, Smetana J, Boštíková V, et al. Použití konjugované pneumokokové vakcíny v dospělosti - nová indikace. Vakcinologie 2012; 6(2): 60-66.
  4. Prymula R. Pneumokokové nákazy a možnosti prevence. Pediatr. prax 2008; 3: 134-137.
  5. Rozenbaum MH, Pechlivanoglou P, van der Werf TS, et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2012 Dec 14. [Epub ahead of print]. Go to original source... Go to PubMed...
  6. Loachimescu OC, Ioachimescu AG, Iannini PB. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Int J AntimicrobAgents. 2004; 24(5): 485-490. Go to original source... Go to PubMed...
  7. Vila-Corcoles A, Ochoa-Gondar O. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview. Expert Rev Vaccines. 2012; 11(2): 221-236. Go to original source... Go to PubMed...
  8. Burgos J, Lujan M, Falcó V, et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis. 2011; 53(3): 254-261. Go to original source... Go to PubMed...
  9. Pande A, Nasir S, Rueda AM, et al. The incidence of necrotizing changes in adults with pneumococcal pneumonia. Clin Infect Dis. 2012; 54(1): 10-16. Go to original source... Go to PubMed...
  10. Marešová V. Riziko pneumokokové pneumonie u dospělých a jeho možné prevence. Abstrakt s. 31. VII. Hradecké vakcinologické dny. 29. 9.-1. 10. 2011, Hradec Králové.
  11. Nelson GE, Gershman KA, Swerdlow DL, et al. Invasive pneumococcal disease and pandemic (H1N1) 200 9, Denver, Colorado, USA. Emerg Infect Dis. 2012; (2): 208-216. Go to original source... Go to PubMed...
  12. Motlová J, Beneš Č, Kozáková J, et al. Invazivní pneumokoková onemocnění v České republice v roce 2011. Zprávy CEM (SZÚ, Praha). 2012; 21(2): 51-58.
  13. Grau I, Ardanuy C, Calatayud L, et al. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS One. 2012; 7(8): e42595. Go to original source... Go to PubMed...
  14. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011; 364(21): 2016-2025. Go to original source... Go to PubMed...
  15. Dzupova O, Rozsypal H, Prochazka B, et al. Acute bacterial meningitis in adults: predictors of outcome. Scand J Infect Dis. 2009; 41(5): 348-354. Go to original source... Go to PubMed...
  16. stergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis. 2005;5: 93. Go to original source... Go to PubMed...
  17. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004; 351(18): 1849-1859. Go to original source... Go to PubMed...
  18. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003; 126(Pt 5): 1015-1025. Go to original source... Go to PubMed...
  19. http://www.vakcinace.eu/data/files/doporucenipropneumovakcinacivdospelosti_2012final.pdf.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.